In Other News

• Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

• Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

• Electronic Genome Mapping Reveals Structural Abnormalities in Hematologic Malignancies

• Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

• Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

• Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

• Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

• Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent

• Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

• Multimodal AI Improves Treatment Response Prediction in Lung Cancer

• Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

• Machine Learning Cytology Tool Improves Cancer Cell Identification

• Updated Ferritin Thresholds Improve Detection of Iron Deficiency

• Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

• FDA Clears Compact Molecular COVID Test for Decentralized Care Settings

• Genetic Studies Uncover Mechanisms Driving Drug Resistance in Klebsiella pneumoniae

• Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

• New Automated Hemostasis Systems Become Available Across US Laboratories

• ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

• Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

• Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework

• Variation in AML Residual Disease Testing Prompts Push for Standardization

• CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing